
Weekly Roundup
By TrendScope Daily Team · November 22, 2026
This was a week where a Wall Street debut, a cricket auction, a movie-franchise cliffhanger, a winter health scare and a wedding reception all fought for the same trending slot in India. If you only have a few minutes, here are the five stories from November 16 to 22, 2026 most worth catching up on, one from each of our beats.
Tech & AI: Anthropic’s Nasdaq debut
Anthropic’s IPO was the week’s biggest tech story, with its stock (ticker ANT) debuting on Nasdaq and immediately becoming a talking point for Indian investors watching the AI sector’s public-market arrival. Read what it means for India →
Entertainment: Ramayana Part 2’s new release date
Ramayana: Part Two is now set for Diwali 2028, a year later than first planned, a date revealed in Part One’s own mid-credit scene alongside Sunny Deol’s casting as Hanuman. Read the full story →
Sports: the IPL 2027 auction
Franchises finalised who they retained and released ahead of the IPL 2027 mega auction, reshaping squads and purse balances across the league well before a ball is bowled next season. See who’s in and who’s out →
Wellness & Lifestyle: Delhi’s winter smog
As Delhi’s air quality index climbed through the week, we looked at exactly what high AQI does to the body and who is most at risk during the worst weeks of winter pollution. Read the health breakdown →
Medicine & Healthcare: a wave of new cancer treatments
In our first week covering this beat on its own, the standout story was the US FDA’s approval of five cancer treatments between early October and mid-November, several cutting disease-progression risk by close to half in trials. What each approval means →
What India was shopping for this week
| Product | Why it trended this week | Where to look |
|---|---|---|
| Galaxy S26 FE / iPhone 17e / Find X9s | Three new mid-flagships compared head-to-head this week | Read our comparison |
| OnePlus 15 | New India pricing and spec comparisons against the iQOO 15 | Read our comparison |
| PDRN face serums | This week’s breakout Korean-beauty ingredient, explained in Sunday’s feature | Search on Amazon.in |
| Protein snacking bars/powders | Ranveer Singh’s SuperYou brand rode India’s continuing protein boom | Read the full story |
| Wireless earbuds | A steady festive-season seller, covered in our budget-to-premium guide | Read our comparison |
As an Amazon Associate, TrendScope Daily earns from qualifying purchases made through links in this article.
Sources: Each story above links to its original TrendScope Daily report, drawing on official company announcements, BCCI/IPL franchise statements, CPCB air-quality data and US FDA approval notices as cited in those articles.
Quick questions
What was the biggest India tech story this week?
Anthropic’s IPO and Nasdaq debut under the ticker ANT, which drew heavy attention from Indian investors following the AI sector’s public markets moment.
What changed for Ramayana Part 2 this week?
Its release date moved from Diwali 2027 to Diwali 2028, confirmed in Part One’s mid-credit scene, which also revealed Sunny Deol as Hanuman.
Were any of this week’s new cancer drugs approved for India?
Not yet. All five are US FDA approvals from October-November 2026; availability in India depends on a separate CDSCO review.
Related on TrendScope Daily
- Today’s trending roundup
- More Tech & AI stories: browse the Tech & AI section
- All our AI explainers: AI Explained hub
- All our health explainers: Health Explained hub
- Today’s full roundup: Trending Today in India: November 22, 2026